Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation

Liver Transplantation

Volumn 16, Issue 2, 2010, Pages 163-171

  Mosbah, Ismail Ben ^j   Roselló Catafau, Joan ^a,b,c   Alfany Fernandez, Izabel ^b   Rimola, Antoni ^c,d   Parellada, Pera Puig ^e   Mitjavila, Maria Teresa ^f   Lojek, Antonin ^g   Abdennebi, Hassen Ben ^h   Boillot, Olivier ⁱ   Rodés, Juan ^c,d   Peralta, Carmen ^b,c  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Faculty of Medicine and Health Sciences   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g INSTITUTE OF BIOPHYSICS   (Czech Republic)

^h UNIVERSITY OF MONASTIR   (Tunisia)

ⁱ EDOUARD HERRIOT HOSPITAL   (France)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BROMSULFOPHTHALEIN; CARVEDILOL; GLUTAMATE DEHYDROGENASE; MALONALDEHYDE; NITRIC OXIDE; PROTEIN KINASE; SUPEROXIDE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE SECRETION; BLOOD FLOW VELOCITY; CELL DAMAGE; CLINICAL PROTOCOL; COLD ISCHEMIA; CONTROLLED STUDY; CRYOPRESERVATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; ENZYME ACTIVITY; EX VIVO STUDY; FATTY LIVER; LIVER CLEARANCE; LIVER DISEASE; LIVER INJURY; LIVER ISCHEMIA; LIVER MITOCHONDRION; LIVER PERFUSION; LIVER PRESERVATION; LIVER PROTECTION; MICROANGIOPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; RAT; REPERFUSION INJURY; VASCULAR RESISTANCE;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ADRENERGIC BETA-ANTAGONISTS; ALLOPURINOL; ANIMALS; BILE; CARBAZOLES; COLD TEMPERATURE; FATTY LIVER; GLUTATHIONE; INSULIN; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; RAFFINOSE; RATS; RATS, ZUCKER; REPERFUSION INJURY; VASCULAR RESISTANCE;

EID: 75449120464     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21968     Document Type: Article

References (41)

1. Imbert CJ, St Peter SD, Handa A, Friend PJ. Hepatic steatosis and its relation to transplantation. Liver Transpl 2002;8:415-423.
2. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105-113.
3. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47:903-905.
4. D'Alessandro A, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knetchle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991;51:157-163.
5. Stratta RJ, Wood RP, Langnas AN, Duckworth RM, Markin RS, Marujo W, et al. The impact of extended preservation on clinical liver transplantation. Transplantation 1990;50: 438-443.
6. Todo S, Nery J, Yanaga K, Podesta L, Gordon RD, Starzl TE. Extended preservation of human liver graft with UW solution. JAMA 1989;261:711-714.
7. El-Gibaly AM, Scheuer C, Menger MD, Vollmar B. Improvement of rat graft liver quality by pifithrin-alpha mediated inhibition of hepatocyte necrapoptosis. Hepatology 2004;39:1553-1562.
8. Klar E, Angelescu M, Zapletal C, Kraus T, Bredt M, Herfarth C. Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation. Transplant Proc 1998;30:3683-3685.
9. Abshagen U. A new molecule with vasodilating and betaadrenoreceptor blocking properties. J Cardiovasc Pharmacol 1987;10:s23-s32.
10. Prichard BN, Tomlinson B. Progress in antihypertensive therapy with a multiple-action drug. Drugs 1988;36:20-25.
11. Kalinowski L, Dobrucki LW, Szczepanska-Konkel M, Jankowski M, Martyniec L, Angielski S, et al. Third generation of beta blockers stimulate nitric oxide release from endothelial cells through ATP efflux. Circulation 2003; 107:2747-2752.
12. Afonso RA, Patarrao RS, Macedo MP, Carmo MM. Carvedilol action is dependent on endogenous production of nitric oxide. Am J Hypertens 2006;19:419-425.
13. Szajerski P, Zielonka J, Sikora A, Adamus J, Marcinek A, Gebicki J, et al. Radical scavenging and NO releasing properties of selected beta adrenoreceptor antagonists. Free Radic Res 2006;40:741-752.
14. Ben Mosbah I, Massip-Salcedo M, Fernández-Monteiro I, Xaus C, Bartrons R, Boillot O, et al. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers. Liver Transpl 2007;13:410-425.
15. Oliveira PJ, Gonçalves L, Monteiro P, Providencia LA, Moreno AJ. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria? Curr Vasc Pharmacol 2005;3:147-158.
16. Carreira R, Duarte A, Monteiro P, Santos MS, Rego AC, Oliveira CR, et al. Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress. Rev Port Cardiol 2004;23:1447-1455.
17. Oliveira PJ, Esteves T, Rolo AP, Monteiro P, Gonçalves L, Palmeira CM, et al. Carvedilol: relation between antioxidant activity and inhibition of the mitochondrial permeability transition. Rev Port Cardiol 2003;22:55-62.
18. Gores GJ, Kost LJ, LaRusso NF. The isolated perfused rat liver: conceptual and practical considerations. Hepatology 1986;6:511-517.
19. Ahmed I, Attia MS, Ahmad N, Lodge JP, Potts DJ. Use of isolated perfused rat liver model for testing liver preservation solutions. Transplant Proc 2001;33:3709-3711.
20. Ben Mosbah I, Rosello-Catafau J, Franco-Gou R, Abdennebi HB, Saidane D, Ramella-Virieux S, et al. Preservation of steatotic livers in IGL-1 solution. Liver Transpl 2006; 12:1215-1223.
21. Yang SP, Ho LJ, Lin YL, Cheng SM, Tsao TP, Chang DM, et al. Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc Res 2003;59: 776-787.
22. Minor T, Yamaguchi T, Isselhard W. Effects of taurine on liver preservation in UW solution with consecutive rewarming in the isolated perfused rat liver. Transpl Int 1995;8:174-179.
23. Minor T, Akbar S, Tolba R, Dombrowski F. Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation. J Hepatol 2000;32:105-111.
24. Ben Abdennebi H, Steghens JP, Hadj-Aissa A, Barbieux A, Ramella-Virieux S, Gharib C, et al. A preservation solution with polyethylene glycol and calcium: a possible multiorgan liquid. Transpl Int 2002;15:348-354.
25. Taneja C, Prescott L, Koneru B. Critical preservation injury in fatty livers is to hepatocytes, not sinusoidal lining cells. Transplantation 1998;65:165-172.
26. Soto A, Foy BD, Frazier JM. Effect of cadmium on bromosulfophthalein kinetics in the isolated perfused rat liver system. Toxicol Sci 2002;69:460-469.
27. Pagano PJ, Ito Y, Tornheim K. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol 1995;268:2274-2280.
28. Peralta C, Bartrons R, Riera L, Manzano A, Xaus C, Gelpí E, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000;279:163-171.
29. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpí E, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemic preconditioning is mediated by activation of adenosine 2 receptors. Hepatology 1999; 29:126-132.
30. Carrasco-Chaumel E, Roselló-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A, et al. Adenosine-monophosphate protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 2005;43:997-1006.
31. Chimalakonda AP, Mehvar R. Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers. Pharm Res 2004; 21:1000-1008.
32. Serafín A, Roselló-Catafau J, Prats N, Gelpí E, Rodés J, Peralta C. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004;39:688-698.
33. Serafín A, Roselló-Catafau J, Prats N, Xaus C, Gelpí E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002;161:587-601.
34. Selzner M, Rüdiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000;32:1280-1288.
35. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE, Moore SB, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992;16:49-53.
36. Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl 2001;7:381-400.
37. Popescu I, Sheiner P, Mor E, Forman W, Borcich A, Emre S, et al. Biliary complications in 400 cases of liver transplantation. Mt Sinai J Med 1994;61:57-62.
38. Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993; 56:495-500.
39. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993;56:1076-1082.
40. Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999;29:1131-1138.
41. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999; 31:430-434.